Displaying 1 - 10 of 27 Results
-
NRDC Comments to the Children’s Health Protection Advisory Committee
CommentsOctober 11, 2018 -
NRDC Letter to Oppose IARC ‘Poison Pill’ Rider in FY19 House Spending Bill
LetterSeptember 13, 2018 -
NRDC Recommendations on IARC Preamble
CommentsSeptember 12, 2018 -
NRDC Comments on EPA TSCA Systematic Review
CommentsAugust 16, 2018 -
NRDC Comments on EPA’s 2017 Glyphosate Draft Human Health & Ecological Risk Assessment, Supporting Registration Review
CommentsApril 30, 2018 -
NRDC Comments on the U.S. EPA’s Registration Reviews of Neonicotinoid Insecticides
CommentsApril 19, 2018 -
Testimony of Dr. Jennifer Sass before the House Science Committee regarding the International Agency for Research on Cancer
TestimonyFebruary 06, 2018 -
NRDC, Scientists and Community Leaders Support National Academies 2018 Review of EPA IRIS Program
LetterJanuary 30, 2018 -
NRDC Comments on EPA Imidacloprid Human Health Draft Risk Assessment
CommentsNovember 13, 2017 -
Comments in Support of Petition to Protect Consumers from Organohalogen Flame Retardants
CommentsSeptember 14, 2017